Your search found 4 Results
Journal of Alternative and Complementary Medicine. 2000 Apr; 6(2):127-129.In recognition of the fact that local communities afflicted by malaria typically use local herbal treatments (Bitahwa et al., 1997 Willcox, 1999)-either with or instead of conventional drugs-this type of new research thinking underpins the agenda of the newly formed Research Initiative for Traditional Antimalarial Methods (RITAM) (Bodeker & Willcox, 2000b). WHO is promoting new drug cocktails, many that are derived from single ingredients of plants, as the new way to combat drug-resistant malaria. The absurd situation has arisen in which synthetic synergism is being sought after it has been rejected in its natural state. The cost of antimalarial cocktails is estimated to be up to seven times that of the already-expensive existing antimalarials. Clearly, a local, sustainable, and affordable response to malaria is called for-one that recognizes that this is where the fight against malaria began and where it continues. (excerpt)
London, England, Earthscan, 1978 Aug. 70 p.This publication is the 1st overall description of the UN drug strategy, involving 5 UN agencies in an undeclared war on the drug companies over "drug colonialism". Tools the agencies are using include a basic drugs list; bulk buying; new patent laws; small-scale manufacturing; and traditional herbs. The ways in which the multinational drug companies work in developing countries is described in detail, in addition to various UN agency policies; results of actions taken by Sri Lanka, India, and other nations against the drug firms; and what industry thinks of the UN plans. Contents of the report include: 1) the Colombo Summit and UN strategy on cooperation among developing nations concerning pharmaceuticals; 2) the structure of the drug industry; high drug prices; drugs for tropical diseases; 3) a basic drugs list: WHO; national lists; industrial and professional resistance; high cost of drugs in Tanzania; industry criticism of essential drug lists; 4) generic versus brand names; 5) bulk purchasing: missions and UNICEF; a UN buying agency; Sri Lanka's experience; regional bulk buying; 6) producing drugs locally through foreign investment: Sri Lanka and India; 7) producing drugs locally through a controlled foreign sector: control of restrictive business practices and patents; 8) producing drugs locally through national self reliance: small-scale plants; barefoot pharmacists; 9) traditional herbs; 10) appropriate drug technologies: fear of the multinationals; quality control; regional drug centers; and 11) primary health care and political will.
World Health. 1978 Aug-Sept; 16-19.Although no plant has yet been scientifically shown to have fertility-regulating effects in humans, peripheral evidence warrants an organized effort in this area. And although large numbers of people in the world use plants as drugs, most notably in China, at present the only plant principles found useful in humans for conditions relating to fertility regulation - the alkaloids sparteine and pachycarpine - cannot be used in a practical way. Perhaps the most interesting agent in plants which has been extensively studied in humans is m-xylohydroquinone, isolated from the common pea. Its antifertility activity was studied in Indian women, but found to be only 60% effective. A thorough reevaluation of this agent might prove useful. The Task Force on Indigenous Plants for Fertility Regulation at WHO has initiated a collaborative effort to conduct laboratory tests on plants alleged to have fertility-regulating properties. The testing procedures are complicated, and although it is too soon to determine results, the untapped potential for development of a plant-derived, safe and inexpensive fertility-regulating agent, is significant.
In: Bannerman RH, Burton J, Ch'en Wen-Chieh. Traditional medicine and health care coverage: a reader for health administrators and practitioners. Geneva, Switzerland, World Health Organization, 1983. 236-78.The various systems of traditional medicine in the countries of the Western Pacific Regions have several characteristics, including a long history, usually dating back many centuries. The resources in medicinal plants are rich, especially in the subtropical and tropical zones, although their development in different countries is unequal. While accepted by the general population, particularly among rural inhabitants, traditional medicine is often rejected or ignored by modern medical practitioners and by the more affluent and educated classes in some countries. Practices observed in the region follow 1 of 2 patterns. 1 model is highly institutionalized, with formal academic training in a variety of disciplines in recognized schools, professional associations, and official recognition. The Chinese system and Hindu medicine practiced in Malaysia, Singapore, Fiji, and Australia follow this pattern. The 2nd pattern is less well defined and institutionalized but nevertheless deeply rooted in the culture of the particular community in which it is practiced. The role of traditional healers in the region; the Chinese system of traditional medicine; traditional medicine in China today including the practice of acupuncture; research in herbal drugs; traditional Chinese medicine in other countries including Vietnam, Malaysia, the Republic of Korea, and Japan; and folk and tribal medicines in the Philippines and rural Malaysia and South Pacific countries such as Papua New Guinea, Kiribati, and Fiji are discussed. WHO stimulates the development of traditional medicine in the region by supporting research, training traditional practitioners and encouraging their integration into health care systems as well as their participation in information sharing publications and activities.